Dr. Bucshon Supports Increased Transparency in Drug Pricing

f t # e
Washington, September 25, 2018 | comments

(Washington, D.C.) –
Congressman Larry Bucshon, M.D. (IN-08) released the following statement in support of the Patients Right to Know Drug Prices Act (s. 2554):

“When a person purchases medications at the pharmacy they probably don’t think that their insurance co-pay could actually end up costing more than simply paying cash for their prescription. Contracts between pharmacy benefit managers and the pharmacy can include a so-called gag clause that prevents the pharmacist from telling a patient that they may be able to pay a lower price if they don’t use their insurance. This is wrong, and Americans should be able to make an informed decision about the best way to pay for their medications.  The Patients Right to Know Drug Prices Act would ban the strangle-hold gag clauses in these contracts that prohibit pharmacists from informing patients of their payment options – using their health insurance or paying out of pocket – and take a small step forward in promoting greater price transparency that can help patients save money when purchasing prescription drugs.”

f t # e

Stay Connected

Use the form below to sign up for my newsletter and get the latest news and updates directly to your inbox.

Office Locations